-transparent.png){kind=logo}
2-Amino-4-phenylpyrrolyl-3-carbonitrile (I) was reacted with ethyl formylacetate sodium salt affording 1,4-dihydro-4-oxo-7-phenylpyrolo[1,2-a]pyrimidin-8-carbonitrile (II), which was alkylated with EtI to give (III), which in turn was hydrolyzed to (IV). Treatment of both (III) and (IV) with 99% H3PO4 at approximately 200 degrees gave 1,4-dihydro-1-ethyl-7-phenylpyrrolo-[1,2-a]pyrimidin-4-one (V) whose structure was ascertained by an unequivocal synthesis starting from (I) and diethyl ethoxymethylenmalonate. Compound (V) was prepared in order to test its pharmacological properties in comparison with 4,7-dihydro-4-ethyl-2-phenylpyrazolo[1,5-a]pyrimidin-7-one, which showed an antiinflammatory activity comparable to that of phenylbutazone and indomethacine, and which was found devoid of ulcerogenic properties.
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 1988,
Acta poloniae pharmaceutica,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
May 1992,
Chemical & pharmaceutical bulletin,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
September 1985,
Il Farmaco; edizione scientifica,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
April 1974,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 1988,
Acta poloniae pharmaceutica,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 1993,
Folia microbiologica,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
April 2003,
Bollettino chimico farmaceutico,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 2003,
Bollettino chimico farmaceutico,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 2017,
Chemistry Central journal,
L Pecori Vettori, and
G Auzzi, and
F Bruni, and
A Costanzo
January 1992,
Polish journal of pharmacology and pharmacy,
